{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T14:59:43Z","timestamp":1793977183671,"version":"4.8.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100001320","name":"Wolfson Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001320","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002283","name":"Alzheimer\u2019s Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002283","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001862","name":"Svenska Forskningsr\u00e5det Formas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001862","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Biomedical Research Council (GOSH)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurodegeneration"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s13024-016-0071-x","type":"journal-article","created":{"date-parts":[[2016,1,11]],"date-time":"2016-01-11T19:57:35Z","timestamp":1452542255000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":306,"title":["Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer\u2019s disease"],"prefix":"10.1186","volume":"11","author":[{"given":"Amanda","family":"Heslegrave","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Heywood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross","family":"Paterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Magdalinou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Svensson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Johansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika","family":"\u00d6hrfelt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaj","family":"Blennow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Hardy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Schott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Mills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,1,12]]},"reference":[{"issue":"3","key":"71_CR1","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1086\/342259","volume":"71","author":"J Paloneva","year":"2002","unstructured":"Paloneva J, Manninen T, Christman G, Hovanes K, Mandelin J, Adolfsson R, et al. Mutations in two genes encoding different subunits of a receptor signaling complex result in an identical disease phenotype. Am J Hum Genet. 2002;71(3):656\u201362.","journal-title":"Am J Hum Genet"},{"issue":"7","key":"71_CR2","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1212\/WNL.59.7.1105","volume":"59","author":"T Kondo","year":"2002","unstructured":"Kondo T, Takahashi K, Kohara N, Takahashi Y, Hayashi S, Takahashi H, et al. Heterogeneity of presenile dementia with bone cysts (Nasu-Hakola disease): three genetic forms. Neurology. 2002;59(7):1105\u20137.","journal-title":"Neurology"},{"issue":"9","key":"71_CR3","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1212\/01.WNL.0000160304.00003.CA","volume":"64","author":"HH Klunemann","year":"2005","unstructured":"Klunemann HH, Ridha BH, Magy L, Wherrett JR, Hemelsoet DM, Keen RW, et al. The genetic causes of basal ganglia calcification, dementia, and bone cysts: DAP12 and TREM2. Neurology. 2005;64(9):1502\u20137.","journal-title":"Neurology"},{"issue":"1","key":"71_CR4","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1001\/jamaneurol.2013.579","volume":"70","author":"RJ Guerreiro","year":"2013","unstructured":"Guerreiro RJ, Lohmann E, Bras JM, Gibbs JR, Rohrer JD, Gurunlian N, et al. Using exome sequencing to reveal mutations in TREM2 presenting as a frontotemporal dementia-like syndrome without bone involvement. JAMA neurology. 2013;70(1):78\u201384.","journal-title":"JAMA neurology"},{"issue":"2","key":"71_CR5","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa1211851","volume":"368","author":"R Guerreiro","year":"2013","unstructured":"Guerreiro R, Wojtas A, Bras J, Carrasquillo M, Rogaeva E, Majounie E, et al. TREM2 variants in Alzheimer\u2019s disease. N Engl J Med. 2013;368(2):117\u201327.","journal-title":"N Engl J Med"},{"issue":"16","key":"71_CR6","first-page":"1567","volume":"369","author":"BA Benitez","year":"2013","unstructured":"Benitez BA, Cruchaga C. TREM2 and neurodegenerative disease. N Engl J Med. 2013;369(16):1567\u20138.","journal-title":"N Engl J Med"},{"key":"71_CR7","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1750-1326-8-19","volume":"8","author":"S Rayaprolu","year":"2013","unstructured":"Rayaprolu S, Mullen B, Baker M, Lynch T, Finger E, Seeley WW, et al. TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson\u2019s disease. Mol Neurodegener. 2013;8:19.","journal-title":"Mol Neurodegener"},{"issue":"3","key":"71_CR8","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.neurobiolaging.2013.09.009","volume":"35","author":"E Cuyvers","year":"2014","unstructured":"Cuyvers E, Bettens K, Philtjens S, Van Langenhove T, Gijselinck I, van der Zee J, et al. Investigating the role of rare heterozygous TREM2 variants in Alzheimer\u2019s disease and frontotemporal dementia. Neurobiol Aging. 2014;35(3):726. e11-9.","journal-title":"Neurobiol Aging"},{"issue":"4","key":"71_CR9","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1001\/jamaneurol.2013.6237","volume":"71","author":"J Cady","year":"2014","unstructured":"Cady J, Koval ED, Benitez BA, Zaidman C, Jockel-Balsarotti J, Allred P, et al. TREM2 variant p.R47H as a risk factor for sporadic amyotrophic lateral sclerosis. JAMA neurology. 2014;71(4):449\u201353.","journal-title":"JAMA neurology"},{"issue":"6","key":"71_CR10","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.jalz.2014.05.1751","volume":"10","author":"CF Slattery","year":"2014","unstructured":"Slattery CF, Beck JA, Harper L, Adamson G, Abdi Z, Uphill J, et al. R47H TREM2 variant increases risk of typical early-onset Alzheimer\u2019s disease but not of prion or frontotemporal dementia. Alzheimer\u2019s & dementia : the journal of the Alzheimer's Association. 2014;10(6):602\u20138. e4.","journal-title":"Alzheimer\u2019s & dementia : the journal of the Alzheimer's Association"},{"issue":"6","key":"71_CR11","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nri1106","volume":"3","author":"M Colonna","year":"2003","unstructured":"Colonna M. TREMs in the immune system and beyond. Nat Rev Immunol. 2003;3(6):445\u201353.","journal-title":"Nat Rev Immunol"},{"issue":"1-2","key":"71_CR12","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jneuroim.2006.11.032","volume":"184","author":"H Neumann","year":"2007","unstructured":"Neumann H, Takahashi K. Essential role of the microglial triggering receptor expressed on myeloid cells-2 (TREM2) for central nervous tissue immune homeostasis. J Neuroimmunol. 2007;184(1-2):92\u20139.","journal-title":"J Neuroimmunol"},{"issue":"6","key":"71_CR13","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.humimm.2013.02.003","volume":"74","author":"A Paradowska-Gorycka","year":"2013","unstructured":"Paradowska-Gorycka A, Jurkowska M. Structure, expression pattern and biological activity of molecular complex TREM-2\/DAP12. Hum Immunol. 2013;74(6):730\u20137.","journal-title":"Hum Immunol"},{"issue":"6","key":"71_CR14","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S1474-4422(14)70090-0","volume":"13","author":"B Dubois","year":"2014","unstructured":"Dubois B, Feldman HH, Jacova C, Hampel H, Molinuevo JL, Blennow K, et al. Advancing research diagnostic criteria for Alzheimer\u2019s disease: the IWG-2 criteria. The Lancet Neurology. 2014;13(6):614\u201329.","journal-title":"The Lancet Neurology"},{"issue":"7","key":"71_CR15","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.neurobiolaging.2011.02.022","volume":"33","author":"LC Souza de","year":"2012","unstructured":"de Souza LC, Chupin M, Lamari F, Jardel C, Leclercq D, Colliot O, et al. CSF tau markers are correlated with hippocampal volume in Alzheimer\u2019s disease. Neurobiol Aging. 2012;33(7):1253\u20137.","journal-title":"Neurobiol Aging"},{"issue":"5","key":"71_CR16","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1001\/archneur.62.5.770","volume":"62","author":"H Hampel","year":"2005","unstructured":"Hampel H, Burger K, Pruessner JC, Zinkowski R, DeBernardis J, Kerkman D, et al. Correlation of cerebrospinal fluid levels of tau protein phosphorylated at threonine 231 with rates of hippocampal atrophy in Alzheimer disease. Arch Neurol. 2005;62(5):770\u20133.","journal-title":"Arch Neurol"},{"issue":"Pt 11","key":"71_CR17","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1093\/brain\/awl269","volume":"129","author":"K Buerger","year":"2006","unstructured":"Buerger K, Ewers M, Pirttila T, Zinkowski R, Alafuzoff I, Teipel SJ, et al. CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer\u2019s disease. Brain : a journal of neurology. 2006;129(Pt 11):3035\u201341.","journal-title":"Brain : a journal of neurology"},{"issue":"20","key":"71_CR18","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1212\/WNL.0b013e3182563bd0","volume":"78","author":"TT Seppala","year":"2012","unstructured":"Seppala TT, Nerg O, Koivisto AM, Rummukainen J, Puli L, Zetterberg H, et al. CSF biomarkers for Alzheimer disease correlate with cortical brain biopsy findings. Neurology. 2012;78(20):1568\u201375.","journal-title":"Neurology"},{"issue":"4","key":"71_CR19","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1212\/01.WNL.0000046581.81650.D0","volume":"60","author":"D Strozyk","year":"2003","unstructured":"Strozyk D, Blennow K, White LR, Launer LJ. CSF Abeta 42 levels correlate with amyloid-neuropathology in a population-based autopsy study. Neurology. 2003;60(4):652\u20136.","journal-title":"Neurology"},{"issue":"3","key":"71_CR20","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1001\/archneurol.2008.596","volume":"66","author":"T Tapiola","year":"2009","unstructured":"Tapiola T, Alafuzoff I, Herukka SK, Parkkinen L, Hartikainen P, Soininen H, et al. Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain. Arch Neurol. 2009;66(3):382\u20139.","journal-title":"Arch Neurol"},{"issue":"6","key":"71_CR21","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.jalz.2013.12.023","volume":"10","author":"FH Duits","year":"2014","unstructured":"Duits FH, Teunissen CE, Bouwman FH, Visser PJ, Mattsson N, Zetterberg H, et al. The cerebrospinal fluid \u201cAlzheimer profile\u201d: easily said, but what does it mean? Alzheimer's & dementia : the journal of the Alzheimer\u2019s Association. 2014;10(6):713\u201323. e2.","journal-title":"Alzheimer's & dementia : the journal of the Alzheimer\u2019s Association"},{"issue":"11","key":"71_CR22","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1136\/jnnp-2014-309562","volume":"86","author":"NK Magdalinou","year":"2015","unstructured":"Magdalinou NK, Paterson RW, Schott JM, Fox NC, Mummery C, Blennow K, et al. A panel of nine cerebrospinal fluid biomarkers may identify patients with atypical parkinsonian syndromes. J Neurol Neurosurg Psychiatry. 2015;86(11):1240\u20137.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"11","key":"71_CR23","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1212\/WNL.0b013e31821103e6","volume":"76","author":"ML Gorno-Tempini","year":"2011","unstructured":"Gorno-Tempini ML, Hillis AE, Weintraub S, Kertesz A, Mendez M, Cappa SF, et al. Classification of primary progressive aphasia and its variants. Neurology. 2011;76(11):1006\u201314.","journal-title":"Neurology"},{"issue":"11","key":"71_CR24","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1016\/j.jprot.2012.03.037","volume":"75","author":"W Heywood","year":"2012","unstructured":"Heywood W, Wang D, Madgett TE, Avent ND, Eaton S, Chitty LS, et al. The development of a peptide SRM-based tandem mass spectrometry assay for prenatal screening of Down syndrome. J Proteomics. 2012;75(11):3248\u201357.","journal-title":"J Proteomics"},{"issue":"5","key":"71_CR25","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1021\/pr301200e","volume":"12","author":"V Manwaring","year":"2013","unstructured":"Manwaring V, Heywood WE, Clayton R, Lachmann RH, Keutzer J, Hindmarsh P, et al. The identification of new biomarkers for identifying and monitoring kidney disease and their translation into a rapid mass spectrometry-based test: evidence of presymptomatic kidney disease in pediatric Fabry and type-I diabetic patients. J Proteome Res. 2013;12(5):2013\u201321.","journal-title":"J Proteome Res"},{"issue":"2","key":"71_CR26","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa1211103","volume":"368","author":"T Jonsson","year":"2013","unstructured":"Jonsson T, Stefansson H, Steinberg S, Jonsdottir I, Jonsson PV, Snaedal J, et al. Variant of TREM2 associated with the risk of Alzheimer\u2019s disease. N Engl J Med. 2013;368(2):107\u201316.","journal-title":"N Engl J Med"},{"issue":"243","key":"71_CR27","doi-asserted-by":"crossref","first-page":"243ra86","DOI":"10.1126\/scitranslmed.3009093","volume":"6","author":"G Kleinberger","year":"2014","unstructured":"Kleinberger G, Yamanishi Y, Suarez-Calvet M, Czirr E, Lohmann E, Cuyvers E, et al. TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis. Sci Transl Med. 2014;6(243):243ra86.","journal-title":"Sci Transl Med"},{"issue":"4","key":"71_CR28","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.celrep.2014.12.041","volume":"10","author":"M Matarin","year":"2015","unstructured":"Matarin M, Salih DA, Yasvoina M, Cummings DM, Guelfi S, Liu W, et al. A genome-wide gene-expression analysis and database in transgenic mice during development of amyloid or tau pathology. Cell Rep. 2015;10(4):633\u201344.","journal-title":"Cell Rep"},{"issue":"4","key":"71_CR29","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","volume":"14","author":"MT Heneka","year":"2015","unstructured":"Heneka MT, Carson MJ, Khoury JE, Landreth GE, Brosseron F, Feinstein DL, et al. Neuroinflammation in Alzheimer\u2019s disease. The Lancet Neurology. 2015;14(4):388\u2013405.","journal-title":"The Lancet Neurology"},{"issue":"Pt 11","key":"71_CR30","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1093\/brain\/awn217","volume":"131","author":"L Piccio","year":"2008","unstructured":"Piccio L, Buonsanti C, Cella M, Tassi I, Schmidt RE, Fenoglio C, et al. Identification of soluble TREM-2 in the cerebrospinal fluid and its association with multiple sclerosis and CNS inflammation. Brain : a journal of neurology. 2008;131(Pt 11):3081\u201391.","journal-title":"Brain : a journal of neurology"},{"issue":"10","key":"71_CR31","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.biopsych.2010.08.025","volume":"68","author":"R Craig-Schapiro","year":"2010","unstructured":"Craig-Schapiro R, Perrin RJ, Roe CM, Xiong C, Carter D, Cairns NJ, et al. YKL-40: a novel prognostic fluid biomarker for preclinical Alzheimer\u2019s disease. Biol Psychiatry. 2010;68(10):903\u201312.","journal-title":"Biol Psychiatry"},{"issue":"1","key":"71_CR32","doi-asserted-by":"crossref","first-page":"130","DOI":"10.2353\/ajpath.2008.080045","volume":"173","author":"D Bonneh-Barkay","year":"2008","unstructured":"Bonneh-Barkay D, Bissel SJ, Wang G, Fish KN, Nicholl GCB, Darko SW, et al. YKL-40, a Marker of Simian Immunodeficiency Virus Encephalitis, Modulates the Biological Activity of Basic Fibroblast Growth Factor. Am J Pathol. 2008;173(1):130\u201343.","journal-title":"Am J Pathol"},{"issue":"6","key":"71_CR33","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1089\/jir.2008.0027","volume":"29","author":"SL Deshmane","year":"2009","unstructured":"Deshmane SL, Kremlev S, Amini S, Sawaya BE. Monocyte chemoattractant protein-1 (MCP-1): an overview. Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research. 2009;29(6):313\u201326.","journal-title":"Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research"},{"issue":"4","key":"71_CR34","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1084\/jem.20041611","volume":"201","author":"K Takahashi","year":"2005","unstructured":"Takahashi K, Rochford CD, Neumann H. Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2. J Exp Med. 2005;201(4):647\u201357.","journal-title":"J Exp Med"},{"issue":"4","key":"71_CR35","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/bpa.12190","volume":"25","author":"LF Lue","year":"2015","unstructured":"Lue LF, Schmitz CT, Serrano G, Sue LI, Beach TG, Walker DG. TREM2 Protein Expression Changes Correlate with Alzheimer\u2019s Disease Neurodegenerative Pathologies in Post-Mortem Temporal Cortices. Brain pathology (Zurich, Switzerland). 2015;25(4):469\u201380.","journal-title":"Brain pathology (Zurich, Switzerland)"},{"issue":"Pt 9","key":"71_CR36","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1093\/brain\/awt231","volume":"136","author":"JM Schott","year":"2013","unstructured":"Schott JM, Revesz T. Inflammation in Alzheimer\u2019s disease: insights from immunotherapy. Brain : a journal of neurology. 2013;136(Pt 9):2654\u20136.","journal-title":"Brain : a journal of neurology"},{"issue":"3","key":"71_CR37","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrneurol.2010.4","volume":"6","author":"K Blennow","year":"2010","unstructured":"Blennow K, Hampel H, Weiner M, Zetterberg H. Cerebrospinal fluid and plasma biomarkers in Alzheimer disease. Nat Rev Neurol. 2010;6(3):131\u201344.","journal-title":"Nat Rev Neurol"}],"container-title":["Molecular Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-016-0071-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T23:31:17Z","timestamp":1498260677000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.molecularneurodegeneration.com\/content\/11\/1\/3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,12]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["71"],"URL":"https:\/\/doi.org\/10.1186\/s13024-016-0071-x","relation":{},"ISSN":["1750-1326"],"issn-type":[{"value":"1750-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,12]]},"article-number":"3"}}